Wearables, Smartphones and Novel Anticoagulants: We Will Treat More Atrial Fibrillation, but Will Patients Be Better Off?

Journal of General Internal Medicine - Germany
doi 10.1007/s11606-016-3761-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

S New Oral Anticoagulants – Will They Be Used With Antiplatelet Drugs in Patients With Atrial Fibrillation After Acute Coronary Syndrome?

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2013English

Will We Be Getting Good Doctors and Safer Patients?

BMJ
2007English

There Will Be More in '54

Chemical and Engineering News
Chemical Engineering
1954English

Whither Professionalization—How Will We Be Judged?

Healthcare Management Forum
Health Policy
1997English

Breeding a Better Cow—Will She Be Adaptable?

Journal of Dairy Science
Animal ScienceZoologyGeneticsFood Science
2018English

MS21.08 Where Will We Be in 10 Years?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Gene Therapy Is Inevitable but Will We Manage?

Biopolymers and Cell
BiochemistryGeneticsMolecular Biology
1991English

Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Cardiovascular and Hematological Disorders - Drug Targets
Molecular MedicinePharmacologyCardiologyHematologyCardiovascular MedicineMedicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy